New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 14, 2013
10:03 EDTALU, XPO, DAKT, JOSB, BRS, THOR, H, ZLTQ, DNKN, TSS, NUVA, MTSN, BPL, MT, BVN, CTCM, GLUU, HSC, IRM, LINTA, AMDOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Alcatel-Lucent (ALU) upgraded to Overweight from Equal Weight at Barclays... ArcelorMittal (MT) upgraded to Outperform from Neutral at Macquarie... Buckeye Partners (BPL) upgraded to Buy from Hold at Deutsche Bank... Buenaventura (BVN) upgraded to Overweight from Neutral at JPMorgan... CTC Media (CTCM) upgraded to Buy from Hold at Deutsche Bank... Glu Mobile (GLUU) upgraded to Buy from Neutral at B. Riley... Harsco (HSC) upgraded to Buy from Hold at BB&T... Iron Mountain (IRM) upgraded to Outperform from Neutral at RW Baird... Liberty Interactive (LINTA) upgraded to Outperform from Market Perform at Wells Fargo... Mattson Technology (MTSN) upgraded to Buy from Neutral at B. Riley... Nokia (NOK) upgraded to Equal Weight from Underweight at Barclays... NuVasive (NUVA) upgraded to Market Perform from Underperform at BMO Capital... TSYS (TSS) upgraded to Outperform from Market Perform at JMP Securities... XPO Logistics (XPO) upgraded to Outperform from Market Perform at FBR Capital... Daktronics (DAKT) upgraded to Buy from Neutral at Sidoti... JoS. A. Bank (JOSB) upgraded to Overweight from Equal Weight at Johnson Rice... Bristow Group (BRS) upgraded to Buy from Speculative Buy at Global Hunter... Hyatt Hotels (H) upgraded to Buy from Neutral at ISI Group... Thoratec (THOR) upgraded to Buy from Neutral at Goldman... ZELTIQ Aesthetics (ZLTQ) upgraded to Buy from Neutral at Goldman... Dunkin' Brands (DNKN) upgraded to Buy from Hold at Miller Tabak... AMD (AMD) upgraded to Outperform from Neutral at Wedbush.
News For ALU;BPL;MT;BVN;CTCM;GLUU;HSC;IRM;LINTA;MTSN;NUVA;TSS;XPO;DAKT;JOSB;BRS;THOR;H;ZLTQ;DNKN;AMD From The Last 14 Days
Check below for free stories on ALU;BPL;MT;BVN;CTCM;GLUU;HSC;IRM;LINTA;MTSN;NUVA;TSS;XPO;DAKT;JOSB;BRS;THOR;H;ZLTQ;DNKN;AMD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
August 8, 2014
08:35 EDTBPLBuckeye Partners reports Q2 EPS 53c, may not compare to consensus 84c
Subscribe for More Information
August 7, 2014
17:06 EDTTHOROn The Fly: Closing Wrap
Stocks on Wall Street began the session in positive territory and appeared ready to build on yesterday’s gains. There was little to point to as a catalyst, but the early move was likely helped by better than expected initial jobless claims data and an agreement to an extended ceasefire by between Gaza and Israel. The market saw its highs shortly after the open and then began to drift lower. By noon each of the major equity indexes had crossed into negative ground and by mid-afternoon the sellers were in control and renewed the selling trend that has been prevalent in recent sessions. ECONOMIC EVENTS: In the U.S., initial jobless claims dropped 14K to 289K in the week ended August 2, versus expectations for 300K new claims. Consumer credit grew by $17.3B in June, versus expectations for it to have increased $18.3B for the month. In Europe, both the European Central Bank and the Bank of England decided to keep their main interest rates unchanged. COMPANY NEWS: 21st Century Fox (FOXA) advanced $1.63, or 5.04%, to $33.96 after the company reported higher than expected fourth quarter earnings and the stock was upgraded to Market Perform from Underperform at Cowen. Chairman and CEO Rupert Murdoch spoke on the company's earnings conference call, which is a bit outside of the recent norm, and said the company's decision to no longer pursue an acquisition of Time Warner (TWX) is "resolute." Chief Operating Officer Chase Carey echoed that the company is "done" as far as Time Warner and added that 21st Century Fox says will not pursue any other content company. MAJOR MOVERS: Among the notable gainers was inContact (SAAS), which gained $1.34, or 17.45%, to $9.02 and was upgraded at Oppenheimer and Benchmark Co. after reporting better than expected Q2 results. Also higher was Stratasys (SSYS), which rose $14.78, or 14.94%, to $113.69 after the company reported stronger than expected second quarter results and raised its guidance. Among the noteworthy losers was Thoratec (THOR), which fell $9.83, or 30.18%, to $22.74 and was downgraded by at least four Street firms following the company's Q2 miss and lowered guidance. Also lower after its earnings report were shares of Coupons.com (COUP), which fell $4.58, or 23.5%, to $14.91. INDEXES: The Dow fell 75.07, or 0.46%, to 16,368.27, the Nasdaq dropped 20.08, or 0.46%, to 4,334.97, and the S&P 500 slipped 10.67, or 0.56%, to 1,909.57.
15:43 EDTBPLNotable companies reporting before tomorrow's open
Subscribe for More Information
14:51 EDTTHORThoratec investors should not move to sidelines, says Barrington
Subscribe for More Information
14:28 EDTTHORThoratec downgraded to Neutral from Buy at BofA/Merrill
Subscribe for More Information
12:14 EDTTHOROn The Fly: Midday Wrap
Subscribe for More Information
10:15 EDTTHORThoratec drops sharply after results, guidance, downgrades
Subscribe for More Information
10:00 EDTTHOROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:08 EDTTHOROn The Fly: Pre-market Movers
Subscribe for More Information
08:20 EDTTHORThoratec downgraded to Neutral from Buy at BTIG
Subscribe for More Information
08:08 EDTTHORThoratec price target lowered to $35 from $41 at Oppenheimer
Oppenheimer cut its price target on Thoratec after the company reported lower than expected revenue and lowered its sales guidance, but reported higher than expected EPS. However, the firm says it has seen significant lumpiness in Thoratec's market before and expects investors' focus to shift to the company's new HeartMate III product. The firm keeps an Outperform rating on the shares.
08:04 EDTZLTQZELTIQ management to meet with Leerink
Meeting to be held in Chicago on August 12 hosted by Leerink.
07:56 EDTTHORThoratec downgraded to Neutral from Outperform at Credit Suisse
Subscribe for More Information
07:42 EDTHSCHarsco sees FY14 adjusted EPS 92c-$1.04, consensus $1.03
07:42 EDTTHORThoratec price target lowered to $28 from $39 at Canaccord
Subscribe for More Information
07:41 EDTHSCHarsco sees Q3 adjusted EPS 26c-31c, consensus 31c
Subscribe for More Information
07:40 EDTHSCHarsco reports Q2 adjusted EPS 17c, consensus 24c
Subscribe for More Information
07:31 EDTTHORThoratec long-term opportunity remains intact, says Leerink
Subscribe for More Information
06:25 EDTTHORThoratec downgraded to Neutral from Outperform at Credit Suisse
Subscribe for More Information
05:37 EDTTHORThoratec downgraded to Neutral from Buy at Goldman
Goldman Sachs downgraded Thoratec to Neutral citing the weaker LVAD market and limited visibility following the company's Q2 results. The firm lowered its price target for shares to $28 from $38. Goldman keeps a Sell rating on peer HeartWare (HTWR) and lowered its price target on the name to $73 from $75.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use